| human | Q5 |
| P496 | ORCID iD | 0000-0002-4828-8096 |
| 0000-0002-7994-9870 |
| P1416 | affiliation | Johns Hopkins School of Medicine | Q858729 |
| Wexner Medical Center at Ohio State University | Q7990266 | ||
| P734 | family name | Pawlik | Q21509427 |
| Pawlik | Q21509427 | ||
| Pawlik | Q21509427 | ||
| P735 | given name | Timothy | Q15885954 |
| Timothy | Q15885954 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q37480871 | 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades |
| Q88623905 | 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers |
| Q90435124 | A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population |
| Q39604716 | A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma |
| Q47750155 | A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy |
| Q91289669 | A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients |
| Q40320310 | A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population |
| Q30277102 | A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. |
| Q96111237 | A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis |
| Q98304365 | A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases |
| Q91044130 | A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B |
| Q114058832 | A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery |
| Q39216171 | A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. |
| Q46109185 | A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. |
| Q47391839 | A Singular Hope: How the Discussion Around Cancer Surgery Sometimes Fails. |
| Q35047903 | A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample. |
| Q37216634 | A comparison of right posterior sectorectomy with formal right hepatectomy: a dual-institution study |
| Q114222116 | A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score |
| Q47378353 | A cross-sectional study of patient and provider perception of "cure" as a goal of cancer surgery. |
| Q57154588 | A minimally invasive technique utilizing percutaneous and endoscopic rendezvous for successful treatment of a proximal bile leak following partial hepatectomy |
| Q104583612 | A mixed-methods approach to comparing perceptions of cancer patients' and cancer care providers' religious and spiritual beliefs, behaviours, and attitudes |
| Q24629242 | A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer |
| Q30276944 | A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma |
| Q88046025 | A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative |
| Q36416303 | A nationwide analysis of the use and outcomes of perioperative epidural analgesia in patients undergoing hepatic and pancreatic surgery |
| Q30366151 | A nomogram to predict disease-free survival after surgical resection of GIST |
| Q43521512 | A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. |
| Q85944067 | A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma |
| Q90027383 | A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm |
| Q37391697 | A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy |
| Q44370691 | A proposed staging system for intrahepatic cholangiocarcinoma |
| Q36821044 | A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma |
| Q37700704 | A risk model to predict 90-day mortality among patients undergoing hepatic resection |
| Q33720743 | A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. |
| Q90606877 | A systematic review of the methods utilised to measure the relationship between cancer patients and oncologists: Implications for future research and practice |
| Q38043734 | A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma |
| Q34398312 | A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer |
| Q90566609 | A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion |
| Q26740057 | ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer |
| Q46392070 | ACR Appropriateness Criteria® Resectable Pancreatic Cancer |
| Q26797499 | ACR Appropriateness Criteria® Resectable Stomach Cancer |
| Q37343420 | ACS-NSQIP has the potential to create an HPB-NSQIP option |
| Q95643673 | ASO Author Reflections: A Nomogram to Predict Recurrence after Curative-Intent Resection for Neuroendocrine Liver Metastasis |
| Q95661462 | ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma |
| Q114058830 | ASO Author Reflections: An Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Patients with Hepatocellular Carcinoma |
| Q94572222 | ASO Author Reflections: Assessing the Outcomes of Liver Cancer Patients Undergoing Surgery Over the Last Decade-Are We Doing Better? |
| Q97591008 | ASO Author Reflections: Centralization of High-Risk Cancer Surgery and Implications for Vulnerable Communities |
| Q90676356 | ASO Author Reflections: Chance of Textbook Outcome following Hepatopancreatic Surgery Varies Based on Cancer Center Designation |
| Q98293796 | ASO Author Reflections: Development and Validation of a Novel Risk Score Using Machine-Learning Methodology to Predict Recurrence After Hepatectomy for Colorectal Liver Metastases |
| Q102384048 | ASO Author Reflections: Hepatocellular Carcinoma-Related Tumor Necrosis is Associated with Worse Long-Term Outcomes |
| Q100512708 | ASO Author Reflections: How Does Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery? |
| Q96766603 | ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently? |
| Q113240778 | ASO Author Reflections: Improving Telehealth Access and Its Implications in a Post-Pandemic Era |
| Q95276190 | ASO Author Reflections: Influence of Patient Clinical- and Treatment-Level Factors on Religious/Spiritual Preferences During Cancer Care |
| Q92006494 | ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer |
| Q97546339 | ASO Author Reflections: Patient Satisfaction and Quality of Care |
| Q91108560 | ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help? |
| Q92006471 | ASO Author Reflections: Routine Lymphadenectomy Should be Recommended Regardless of Morphologic Subtype of Intrahepatic Cholangiocarcinoma |
| Q91943582 | ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines? |
| Q91934053 | ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment |
| Q91237053 | ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies |
| Q98936118 | ASO Author Reflections: Validated Prediction Model of Early Recurrence after Resection for Gallbladder Cancer: Identifying a Subset of Patients Who May be Better Served with Neoadjuvant Therapy |
| Q91729240 | ASO Author Reflections: Which Patients Benefit the Most From Lymphadenectomy During Resection for Intrahepatic Cholangiocarcinoma? |
| Q114058829 | ASO Visual Abstract: A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for HCC Patients Undergoing Curative-Intent Surgery |
| Q104692639 | ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? |
| Q39177703 | Accelerated Partial Breast Irradiation as an Alternative to Whole-Breast Irradiation in Breast-Conserving Therapy for Early-Stage Breast Cancer |
| Q37608389 | Accelerated partial breast irradiation as an alternative to whole breast irradiation in breast-conserving therapy for early-stage breast cancer |
| Q89886330 | Accessing surgical care for esophageal cancer: patient travel patterns to reach higher volume center |
| Q91181342 | Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers |
| Q36534796 | Accuracy of marketing claims by providers of stereotactic radiation therapy |
| Q51737695 | Accuracy of the ACS NSQIP Online Risk Calculator Depends on How You Look at It: Results from the United States Gastric Cancer Collaborative. |
| Q36980397 | Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature |
| Q79774783 | Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma |
| Q39708324 | Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases |
| Q37613080 | Actual 10-year survivors following resection of adrenocortical carcinoma |
| Q90420300 | Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma |
| Q86854244 | Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis |
| Q90407045 | Adjuvant Therapy for Biliary Tract Cancers: New Evidence to Resolve Old Questions |
| Q33735469 | Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study |
| Q33733149 | Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma |
| Q36579942 | Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas |
| Q36979093 | Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater |
| Q36579200 | Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas |
| Q90174138 | Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit |
| Q48336081 | Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium. |
| Q37114016 | Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. |
| Q33797067 | Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization |
| Q90295857 | Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma |
| Q35766128 | Advances in the surgical management of liver malignancies |
| Q38230654 | Advances in understanding of colorectal liver metastasis and implications for the clinic |
| Q39068696 | Age of Transfused Blood Impacts Perioperative Outcomes Among Patients Who Undergo Major Gastrointestinal Surgery |
| Q40404238 | Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection |
| Q35096027 | Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases |
| Q53430743 | An advance care plan decision support video before major surgery: a patient- and family-centred approach. |
| Q40663411 | An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative |
| Q36572889 | Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital |
| Q57781143 | Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis |
| Q50918782 | Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases. |
| Q47444830 | Antiviral Therapy Improves Survival in patients with HBV infection and Intrahepatic Cholangiocarcinoma undergoing Liver Resection. |
| Q94597117 | Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers |
| Q33742388 | Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study |
| Q88936984 | Assessing coding practices for gastrointestinal surgery over time in the United States |
| Q36216075 | Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. |
| Q37723397 | Assessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer |
| Q90874353 | Assessing structure and characteristics of social networks among cancer survivors: impact on general health |
| Q87082090 | Assessing the Costs Associated with Volume-Based Referral for Hepatic Surgery |
| Q38804328 | Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer |
| Q50027558 | Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy |
| Q35047660 | Assessing the experience in complex hepatopancreatobiliary surgery among graduating chief residents: is the operative experience enough? |
| Q33742372 | Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer |
| Q98304467 | Assessment of Cancer Center Variation in Textbook Oncologic Outcomes Following Colectomy for Adenocarcinoma |
| Q40216373 | Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma. |
| Q89987671 | Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma |
| Q30252588 | Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System |
| Q82255436 | Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma |
| Q89488530 | Assessment of utilization efficiency using machine learning techniques: A study of heterogeneity in preoperative healthcare utilization among super-utilizers |
| Q36416491 | Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. |
| Q91993349 | Association Between Travel Distance, Hospital Volume, and Outcomes Following Resection of Cholangiocarcinoma |
| Q56969146 | Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer |
| Q98304480 | Association of County-Level Social Vulnerability with Elective Versus Non-elective Colorectal Surgery |
| Q38659981 | Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery |
| Q97654166 | Association of Neighborhood Characteristics with Utilization of High-Volume Hospitals Among Patients Undergoing High-Risk Cancer Surgery |
| Q39247024 | Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. |
| Q57469823 | Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma |
| Q40163620 | Association of Safety Culture with Surgical Site Infection Outcomes |
| Q64092695 | Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma |
| Q88674197 | Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium |
| Q50209984 | Association of shared decision-making on patient-reported health outcomes and healthcare utilization |
| Q36716918 | Associations Between Patient Perceptions of Communication, Cure, and Other Patient-Related Factors Regarding Patient-Reported Quality of Care Following Surgical Resection of Lung and Colorectal Cancer. |
| Q87969176 | Attrition in general surgery residency: can global and rural surgery shift the paradigm? |
| Q53148517 | Avoiding immortal time bias in the American College of Surgeons National Surgical Quality Improvement Program readmission measure. |
| Q33924966 | Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer |
| Q35213015 | Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy |
| Q87730974 | Benchmarking the Scientific and Educational Impact of the Annals of Surgical Oncology |
| Q40149084 | Benefits of Bowel Preparation Beyond Surgical Site Infection: A Retrospective Study |
| Q45882479 | Biliary tract and primary liver tumors |
| Q83229751 | Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more |
| Q28266656 | Biology of hepatocellular carcinoma |
| Q50971533 | Blood Transfusion Strategy and Clinical Outcomes. |
| Q38664200 | Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group |
| Q39869150 | Blood loss and outcomes after resection of colorectal liver metastases |
| Q34078971 | Body mass index and adverse perioperative outcomes following hepatic resection. |
| Q48847775 | Bundled Payments for Surgical Colectomy Among Medicare Enrollees: Potential Savings vs the Need for Further Reform |
| Q91623872 | CMS Hospital Compare System of Star Ratings and Surgical Outcomes Among Patients Undergoing Surgery for Cancer: Do the Ratings Matter? |
| Q28383327 | Cadmium exposure and liver disease among US adults |
| Q42958025 | Can Physicians Refuse Treatment to Patients Who Smoke? |
| Q91043167 | Can We Improve Prediction of Adverse Surgical Outcomes? Development of a Surgical Complexity Score Using a Novel Machine Learning Technique |
| Q41492478 | Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? |
| Q85915141 | Can the risk of non-home discharge after resection of gastric adenocarcinoma be predicted: a seven-institution study of the US Gastric Cancer Collaborative |
| Q86533098 | Can video recording revolutionise medical quality? |
| Q54413905 | Cancer surgeons' attitudes and practices about discussing the chance of operative "cure". |
| Q44364782 | Carcinoid tumor of the biliary tract: treating a rare cause of bile duct obstruction. |
| Q60629744 | Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis |
| Q44578514 | Central role of interleukin-6 in burn induced stimulation of hepatic amino acid transport. |
| Q57115722 | Challenges of surgical management of intrahepatic cholangiocarcinoma |
| Q49500942 | Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. |
| Q41934377 | Characterization of the Immune Microenvironment in Hepatocellular Carcinoma (HCC). |
| Q98476472 | Characterizing Pastoral Care Utilization by Cancer Patients |
| Q91652924 | Characterizing Perceptions Around the Patient-Oncologist Relationship: a Qualitative Focus Group Analysis |
| Q50947280 | Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. |
| Q36464103 | Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases |
| Q57134289 | Cholangiocarcinoma risk factors and the potential role of aspirin |
| Q98215237 | Cholangiocarcinoma: investigations into pathway-targeted therapies |
| Q42671766 | Cholecystectomy and wound complications: smoking worsens risk |
| Q81253614 | Choledochal cyst disease in children and adults: a 30-year single-institution experience |
| Q35095917 | Choledochal cysts: presentation, clinical differentiation, and management |
| Q43486733 | Choosing a cancer surgeon: analyzing factors in patient decision making using a best-worst scaling methodology. |
| Q47217492 | Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients |
| Q40509855 | Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. |
| Q93002929 | Clinical Utility of Autologous Salvaged Blood: a Review |
| Q87283523 | Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma |
| Q98387371 | Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2 cm |
| Q57781151 | Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence |
| Q84896715 | Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis |
| Q30602517 | Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium |
| Q35948141 | Clinicopathologic features in colorectal cancer patients with microsatellite instability |
| Q49345313 | Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer |
| Q43976070 | Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study |
| Q90936436 | Coaxial projective imaging system for surgical navigation and telementoring |
| Q39722702 | Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases |
| Q40054265 | Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. |
| Q58804371 | Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma |
| Q87927195 | Colon Cancer |
| Q57178427 | Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing? |
| Q35940604 | Colorectal carcinogenesis: MSI-H versus MSI-L. |
| Q35687594 | Colorectal liver metastases |
| Q37346951 | Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation |
| Q43798315 | Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection |
| Q39132542 | Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes |
| Q79247725 | Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients |
| Q91510090 | Comment on: Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer |
| Q38353727 | Comparative effectiveness in hepatic malignancies |
| Q42553272 | Comparative performances of staging systems for early hepatocellular carcinoma |
| Q30274781 | Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma |
| Q96233023 | Comparing Surgeon Approaches to Patient-Centered Cancer Care Using Vignette Methodology |
| Q89987652 | Comparing textbook outcomes among patients undergoing surgery for cancer at U. S. News & World Report ranked hospitals |
| Q82039311 | Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases |
| Q36416250 | Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach |
| Q34013772 | Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning |
| Q90259686 | Complex hepato-pancreato-biliary caseload during general surgery residency training: are we adequately training the next generation? |
| Q40629966 | Complication timing impacts 30-d mortality after hepatectomy |
| Q91339233 | Complications after liver surgery: a benchmark analysis |
| Q34770140 | Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma |
| Q30300259 | Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients |
| Q95577168 | Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis |
| Q30300823 | Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients |
| Q42627555 | Conditional probability of long-term survival after resection of hilar cholangiocarcinoma |
| Q39879458 | Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients |
| Q85692239 | Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative |
| Q36626623 | Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. |
| Q87929953 | Consideration of KRAS Mutational Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET Scan, in Patients With Colorectal Liver Metastases |
| Q90645330 | Correction to: Current Approaches in the Management of Hepatic Adenomas |
| Q101147370 | Correction to: Defining and Predicting Early Recurrence After Resection for Gallbladder Cancer |
| Q90140533 | Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery |
| Q93274839 | Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis |
| Q38690359 | Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma |
| Q36737647 | Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic |
| Q47682854 | Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective? |
| Q99368956 | County-Level Variation in Utilization of Surgical Resection for Early-Stage Hepatopancreatic Cancer Among Medicare Beneficiaries in the USA |
| Q81752827 | Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma |
| Q80403412 | Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408) |
| Q53388175 | Crystalloid administration among patients undergoing liver surgery: Defining patient- and provider-level variation. |
| Q37129653 | Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence |
| Q37153124 | Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. |
| Q94913559 | Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma |
| Q57169483 | Current Approaches in the Management of Hepatic Adenomas |
| Q38663025 | Current Management of Perihilar Cholangiocarcinoma and Future Perspectives |
| Q37436486 | Current management of colorectal hepatic metastasis |
| Q90094710 | Current state of the art imaging approaches for colorectal liver metastasis |
| Q47576721 | Cutaneous angiosarcoma of the scalp: a multidisciplinary approach |
| Q30408809 | Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma |
| Q45068870 | Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis |
| Q83070102 | Debate: Resection for early hepatocellular carcinoma |
| Q82457824 | Debunking dogma: surgery for four or more colorectal liver metastases is justified |
| Q89934389 | Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery |
| Q50060693 | Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium. |
| Q40499240 | Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma |
| Q40928140 | Defining Transfusion Triggers and Utilization of Fresh Frozen Plasma and Platelets Among Patients Undergoing Hepatopancreaticobiliary and Colorectal Surgery. |
| Q100694874 | Defining and Predicting Early Recurrence After Resection for Gallbladder Cancer |
| Q99202698 | Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer |
| Q90678503 | Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study |
| Q33650840 | Defining incidence and risk factors of venous thromboemolism after hepatectomy. |
| Q47406431 | Defining payments associated with the treatment of colorectal cancer |
| Q40399436 | Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer |
| Q90670284 | Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients |
| Q30277031 | Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis |
| Q36110741 | Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma |
| Q46194466 | Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio |
| Q89515749 | Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma |
| Q52730150 | Development and prospective validation of a model estimating risk of readmission in cancer patients. |
| Q52601243 | Diagnostic and Therapeutic Implications of Novel Peptides in Hepatocellular Carcinoma. |
| Q96643876 | Diaphragmatic Involvement Should Not Preclude Curative-Intent Surgical Resection for Hepatocellular Carcinoma |
| Q36512761 | Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes |
| Q37788614 | Disappearing Colorectal Liver Metastases after Chemotherapy: Should we be Concerned? |
| Q39060077 | Discharge decision-making after complex surgery: Surgeon behaviors compared to predictive modeling to reduce surgical readmissions |
| Q39638890 | Disclosure of "nonharmful" medical errors and other events: duty to disclose |
| Q92608960 | Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective |
| Q40407836 | Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium |
| Q95332865 | Do Religious/Spiritual Preferences and Needs of Cancer Patients Vary Based on Clinical- and Treatment-Level Factors? |
| Q49581342 | Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? |
| Q42634819 | Does relative value unit-based compensation shortchange the acute care surgeon? |
| Q92583575 | Does spiritual and religious orientation impact the clinical practice of healthcare providers? |
| Q51271244 | Doing more: trends in breast cancer surgery, 2005 to 2011. |
| Q36874146 | Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment |
| Q91078635 | Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined |
| Q58096352 | Early Morbidity and Mortality after Minimally Invasive Liver Resection for Hepatocellular Carcinoma: a Propensity-Score Matched Comparison with Open Resection |
| Q38668755 | Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment |
| Q90019978 | Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis |
| Q36252523 | Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy |
| Q90720479 | Early mortality after liver transplantation: Defining the course and the cause |
| Q36580127 | Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer |
| Q91810948 | Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome |
| Q41207930 | Early versus late hospital readmission after pancreaticoduodenectomy. |
| Q40641819 | Early versus late readmission after surgery among patients with employer-provided health insurance. |
| Q45074449 | Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. |
| Q80594622 | Echogenic appearance of colorectal liver metastases on intraoperative ultrasonography is associated with survival after hepatic resection |
| Q39490726 | Educating the surgeon-scientist: A qualitative study evaluating challenges and barriers toward becoming an academically successful surgeon |
| Q39041094 | Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma |
| Q49594080 | Effect of Increased Intra-abdominal Pressure on Liver Histology and Hemodynamics: An Experimental Study |
| Q39968679 | Effect of Index Hospitalization Costs on Readmission Among Patients Undergoing Major Abdominal Surgery |
| Q41666883 | Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. |
| Q41529022 | Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. |
| Q93055619 | Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis |
| Q36829154 | Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis |
| Q51808673 | Effect of surgeon "experience" with laparoscopy on postoperative outcomes after colorectal surgery. |
| Q40570136 | Effect of surgeon and anesthesiologist volume on surgical outcomes |
| Q34557044 | Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases |
| Q41487661 | Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization |
| Q35028999 | Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. |
| Q41664127 | Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. |
| Q36512778 | Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies |
| Q38923539 | Emerging role of Hpo signaling and YAP in hepatocellular carcinoma |
| Q37734298 | Emerging therapeutic approaches to hepatocellular carcinoma |
| Q36167838 | Endometrial stromal sarcoma presenting as large bleeding left upper quadrant mass |
| Q37718476 | Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery |
| Q86787567 | Endoscopic ultrasound may misclassify the nodal status of a small subset of patients with early gastric cancer: in reply to Chen and colleagues |
| Q38282668 | Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation. |
| Q86100014 | Epidemiology of hepatocellular carcinoma |
| Q53346679 | Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis. |
| Q87474814 | Erratum to: Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia |
| Q36099742 | Ethical issues in surgical palliative care: am I killing the patient by "letting him go"? |
| Q48611146 | Ethics and the law: is there common ground on informed consent for disparities in hospital outcomes? |
| Q39215948 | Evaluating Trends in the Volume-Outcomes Relationship Following Liver Surgery: Does Regionalization Benefit All Patients the Same? |
| Q40058301 | Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium. |
| Q34008107 | Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer |
| Q46575353 | Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience |
| Q35477482 | Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study |
| Q90752433 | Evaluation of costs and outcomes of physician-owned hospitals across common surgical procedures |
| Q39740700 | Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. |
| Q40162221 | Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis. |
| Q92775414 | Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma |
| Q37507732 | Evolving treatment strategies for gallbladder cancer |
| Q89514975 | Examining healthcare inequities relative to United States safety net hospitals |
| Q33581027 | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas |
| Q50103625 | Exosomes in Pancreatic Cancer: from Early Detection to Treatment |
| Q37075581 | Expanding criteria for resectability of colorectal liver metastases |
| Q92175760 | Exploring the perception of survivors on the bidirectional impact between cancer and their social contexts: A mixed-methods approach |
| Q38949027 | Factors Associated With Interhospital Variability in Inpatient Costs of Liver and Pancreatic Resections. |
| Q86570701 | Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative |
| Q53292196 | Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. |
| Q36626566 | Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma |
| Q92971451 | Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery |
| Q81871804 | Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer |
| Q37031777 | Fibrolamellar hepatocellular carcinoma: current clinical perspectives |
| Q38926902 | Financial Impact of Postoperative Complication Following Hepato-Pancreatico-Biliary Surgery for Cancer |
| Q93007284 | Financial toxicity risk among adult patients undergoing cancer surgery in the United States: An analysis of the National Inpatient Sample |
| Q38925785 | Frailty as a Risk Predictor of Morbidity and Mortality Following Liver Surgery |
| Q38827380 | From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis. |
| Q37339028 | Functional MR imaging as a new paradigm for image guidance |
| Q35163735 | Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma |
| Q38790162 | Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable? |
| Q41174134 | Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer? |
| Q52565228 | Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. |
| Q30405398 | Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets |
| Q90931430 | Geographic Distribution of Adult Inpatient Surgery Capability in the USA |
| Q38200403 | Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma |
| Q33986084 | Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study |
| Q37994417 | Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis |
| Q38528603 | Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis. |
| Q61848144 | Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease |
| Q91459564 | Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter? |
| Q90752241 | Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome |
| Q33622797 | Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome |
| Q35791389 | Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. |
| Q80974190 | Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma |
| Q53266271 | Hepatobiliary cancers, version 2.2014. |
| Q89710647 | Hepatocellular carcinoma tumour burden score to stratify prognosis after resection |
| Q54306171 | Hepatocellular carcinoma: From diagnosis to treatment. |
| Q90569312 | Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials |
| Q38190226 | Hepatocellular carcinoma: diagnosis, management, and prognosis |
| Q90762710 | Hepatopancreatobiliary Surgery: the Role of Clinical Resources and Variation in Performance of Hospitals Located in "Distressed" Communities |
| Q35692230 | Hereditary pancreatic and hepatobiliary cancers |
| Q34661001 | Hilar cholangiocarcinoma: diagnosis, treatment options, and management |
| Q35840986 | Hilar cholangiocarcinoma: tumor depth as a predictor of outcome |
| Q36221363 | Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas |
| Q91759920 | Hospice utilization among Medicare beneficiaries dying from pancreatic cancer |
| Q88127924 | Hospital Teaching Status and Medicare Expenditures for Hepato-Pancreato-Biliary Surgery |
| Q38701122 | Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. |
| Q39785157 | Hospital markup and operation outcomes in the United States |
| Q39845663 | Hospital readmission after multiple major operative procedures among patients with employer provided health insurance |
| Q41710316 | Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough? |
| Q91624983 | How Safe Are Safety-Net Hospitals? Opportunities to Improve Outcomes for Vulnerable Patients Undergoing Hepatopancreaticobiliary Surgery |
| Q30585821 | Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis |
| Q64262106 | Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity |
| Q55378664 | Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. |
| Q40695945 | IMPROVING SAFE PATIENT THROUGHPUT IN A MULTIDISCIPLINARY ONCOLOGY CLINIC. |
| Q58295338 | Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis? |
| Q88570154 | Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation |
| Q58545469 | Identifying Hospital Cost Savings Opportunities by Optimizing Surgical Approach for Distal Pancreatectomy |
| Q50465290 | Identifying variations in blood use based on hemoglobin transfusion trigger and target among hepatopancreaticobiliary surgeons. |
| Q83482310 | Image of the month. Gastrohepatic fistula following TACE for HCC |
| Q42133533 | Image of the month. Recurrent metastatic HCC |
| Q53047344 | Images of the month. Hydatid disease. |
| Q38190223 | Imaging of the patient with a biliary tract or primary liver tumor |
| Q90094702 | Immunotherapy utilization for hepatobiliary cancer in the United States: disparities among patients with different socioeconomic status |
| Q36833793 | Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia |
| Q40462627 | Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer. |
| Q33757744 | Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis |
| Q39328907 | Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery. |
| Q91344176 | Impact of Liver Cirrhosis on Perioperative Outcomes Among Elderly Patients Undergoing Hepatectomy: the Effect of Minimally Invasive Surgery |
| Q89309144 | Impact of Perioperative Phosphorus and Glucose Levels on Liver Regeneration and Long-term Outcomes after Major Liver Resection |
| Q88141713 | Impact of Post-Discharge Disposition on Risk and Causes of Readmission Following Liver and Pancreas Surgery |
| Q91348530 | Impact of Preoperative Cholangitis on Short-term Outcomes Among Patients Undergoing Liver Resection |
| Q92037868 | Impact of Surgeon Volume on Outcomes and Expenditure Among Medicare Beneficiaries Undergoing Liver Resection: the Effect of Minimally Invasive Surgery |
| Q47392655 | Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis. |
| Q88527863 | Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC |
| Q39041689 | Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients |
| Q45063804 | Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis |
| Q37692140 | Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis |
| Q41523146 | Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. |
| Q30300137 | Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma |
| Q91339230 | Impact of concomitant ablation on the perioperative outcomes of patients with colorectal liver metastases undergoing hepatectomy: a propensity score matched nationwide analysis |
| Q87915100 | Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis |
| Q88161601 | Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer |
| Q37693431 | Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA. |
| Q40174052 | Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy |
| Q30252624 | Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis |
| Q93351681 | Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma |
| Q43548469 | Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study |
| Q37695686 | Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies |
| Q36626534 | Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma |
| Q91295245 | Impact of skilled nursing facility quality on postoperative outcomes after pancreatic surgery |
| Q81353703 | Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis |
| Q90393386 | Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases |
| Q40100491 | Implementation Costs of an Enhanced Recovery After Surgery Program in the United States: A Financial Model and Sensitivity Analysis Based on Experiences at a Quaternary Academic Medical Center |
| Q58076449 | Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases |
| Q47663861 | Implementation of a Blood Management Program at a Tertiary Care Hospital: Effect on Transfusion Practices and Clinical Outcomes Among Patients Undergoing Surgery |
| Q45066722 | Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study |
| Q88118623 | Improvement of the Surgical Apgar Score by Addition of Intraoperative Blood Transfusion Among Patients Undergoing Major Gastrointestinal Surgery |
| Q48411897 | Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis |
| Q42642468 | Improving surgical outcomes through adoption of evidence-based process measures: intervention specific or associated with overall hospital quality? |
| Q91778240 | In-hospital Mortality Following Pancreatoduodenectomy: a Comprehensive Analysis |
| Q24609544 | Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma |
| Q37109362 | Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma |
| Q90417985 | Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group |
| Q81753347 | Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience |
| Q35012020 | Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases |
| Q37119585 | Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. |
| Q50189109 | Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. |
| Q40955030 | Inclusion of Sarcopenia Outperforms the Modified Frailty Index in Predicting 1-Year Mortality among 1,326 Patients Undergoing Gastrointestinal Surgery for a Malignant Indication |
| Q42615230 | Increased complications after appendectomy in patients with cerebral palsy: are special needs patients at risk for disparities in outcomes? |
| Q38731568 | Increased kinetic growth rate during late phase liver regeneration impacts the risk of tumor recurrence after colorectal liver metastases resection |
| Q89250833 | Independent Predictors of Increased Operative Time and Hospital Length of Stay Are Consistent Across Different Surgical Approaches to Pancreatoduodenectomy |
| Q53058372 | Indeterminate left-sided retroperitoneal mass. |
| Q90435087 | Index versus Non-index Readmission After Hepato-Pancreato-Biliary Surgery: Where Do Patients Go to Be Readmitted? |
| Q44496044 | Infected primary retroperitoneal teratoma presenting as a subhepatic abscess in a postpartum woman |
| Q37897153 | Infiltrating hepatocellular carcinoma: seeing the tree through the forest |
| Q64998673 | Influence of English proficiency on patient-provider communication and shared decision-making. |
| Q58112226 | Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection |
| Q47196961 | Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma |
| Q37698496 | Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States |
| Q47593268 | Informed consent and the surgeon |
| Q50045466 | Innovation in the Diagnosis and Management of Breast Cancer |
| Q40184058 | Inpatient survival after gastrectomy for gastric cancer in the 21st century |
| Q92736888 | Insurance Coverage Type Impacts Hospitalization Patterns Among Patients with Hepatopancreatic Malignancies |
| Q100753793 | Insurance status and high-volume surgical cancer: Access to high-quality cancer care |
| Q36820283 | Integrating partial breast irradiation into surgical practice and clinical trials |
| Q53139739 | Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative. |
| Q91348519 | Interaction of Surgeon Volume and Nurse-to-Patient Ratio on Post-operative Outcomes of Medicare Beneficiaries Following Pancreaticoduodenectomy |
| Q50185186 | Interhospital transfer and adverse outcomes after general surgery: implications for pay for performance. |
| Q35234472 | Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma |
| Q50619530 | Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver. |
| Q34654186 | Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. |
| Q30472534 | Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation |
| Q79124490 | Intracavitary balloon brachytherapy for breast cancer: surgical considerations. in regard to Keisch M, Vicini F, Kuske RR, et al., IJROBP 2003;55:289–293 |
| Q57145895 | Intraductal papillary mucinous neoplasm of the liver: GI image |
| Q60675548 | Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment |
| Q30278517 | Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy |
| Q38013020 | Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response |
| Q53312000 | Intrahepatic cholangiocarcinoma. |
| Q38746915 | Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis |
| Q39186928 | Intrahepatic cholangiocarcinoma: current management and emerging therapies |
| Q35924971 | Intrahepatic cholangiocarcinoma: expert consensus statement. |
| Q40448771 | Intrahepatic cholangiocarcinoma: from diagnosis to treatment. |
| Q38124537 | Intrahepatic cholangiocarcinoma: management options and emerging therapies |
| Q100306274 | Intrapersonal Factors Impact Advance Care Planning Among Cancer Patients |
| Q90122243 | Introducing Research Communications to the Journal of Gastrointestinal Surgery |
| Q90155766 | Is Annual Preoperative Utilization an Indicator of Postoperative Surgical Outcomes? A Study in Medicare Expenditure |
| Q48097067 | Is BMI associated with post-operative complication risk among patients undergoing major abdominal surgery for cancer? A systematic review. |
| Q30359582 | Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. |
| Q37166464 | Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. |
| Q97427428 | Is Patient Satisfaction Dictated by Quality of Care Among Patients Undergoing Complex Surgical Procedures for a Malignant Indication? |
| Q53024360 | Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. |
| Q91173058 | Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis |
| Q79922197 | Is extended hepatectomy for hepatobiliary malignancy justified? |
| Q81783133 | Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database |
| Q48621391 | Is it ethical to send patients to low-volume hospitals for cancer surgery? |
| Q37657085 | Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? |
| Q85791072 | Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative |
| Q38942566 | Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature. |
| Q81450234 | Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? |
| Q42149556 | Is there an association between implementation of a medical team training program and surgical mortality? |
| Q38013021 | Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization. |
| Q53017398 | KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases. |
| Q52722138 | Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature. |
| Q42337440 | Laparoscopic hepatectomy for hepatocellular carcinoma: are oncologic outcomes truly superior to an open approach? |
| Q31135593 | Limitations of claims and registry data in surgical oncology research |
| Q38543212 | Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. |
| Q38925280 | Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis |
| Q90931436 | Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC |
| Q24540174 | Liver Transplantation for Hepatocellular Carcinoma: Need for a New Patient Selection Strategy: Reply |
| Q83159185 | Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy |
| Q88502092 | Liver hypoxia as a trigger to liver regeneration: No more than another piece of the puzzle |
| Q35155607 | Liver metastasis as the initial presentation of adenoid cystic carcinoma |
| Q53127104 | Liver regeneration after major liver hepatectomy: Impact of body mass index. |
| Q34625619 | Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. |
| Q90804477 | Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patients |
| Q39312884 | Liver transplantation for unresectable colorectal liver metastases: A systematic review. |
| Q36408076 | Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review |
| Q80435200 | Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis |
| Q38214268 | Liver-directed therapies: surgical approaches, alone and in combination with other interventions. |
| Q84370438 | Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis |
| Q89994653 | Local referrals as a strategy for increasing value of surgical care among medicare patients undergoing liver and pancreatic surgery |
| Q38081661 | Local therapies for hepatic metastases. |
| Q89632182 | Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group |
| Q58876714 | Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma |
| Q91486837 | Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial |
| Q43882412 | Long-term health-related quality of life after iatrogenic bile duct injury repair. |
| Q37029750 | Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features. |
| Q56355702 | Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma |
| Q40792612 | Long-term therapy with sorafenib is associated with pancreatic atrophy. |
| Q36416354 | Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems |
| Q39426991 | Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? |
| Q47230003 | Lymphadenectomy for Intrahepatic Cholangiocarcinoma: Has Nodal Evaluation Been Increasingly Adopted by Surgeons over Time?A National Database Analysis |
| Q35740606 | Lymphatic mapping in the molecular era. |
| Q36842981 | Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer |
| Q36363334 | Making unresectable hepatic colorectal metastases resectable--does it work? |
| Q35084330 | Malignant melanoma: current state of primary and adjuvant treatment |
| Q54200140 | Malignant transformation of hepatic adenomas. |
| Q30279208 | Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection |
| Q64042017 | Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis |
| Q91829047 | Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis |
| Q30252389 | Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis |
| Q34642543 | Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients |
| Q90164709 | Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors |
| Q38823634 | Management of Type 9 Hepatic Arterial Anatomy at the time of Pancreaticoduodenectomy: Considerations for Preservation and Reconstruction of a Completely Replaced Common Hepatic Artery. |
| Q30360985 | Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. |
| Q38737093 | Management of choledochal cysts. |
| Q83440082 | Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis |
| Q37682720 | Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature |
| Q38258604 | Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review |
| Q36626617 | Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy |
| Q28273788 | Management of perihilar cholangiocarcinoma in the era of multimodal therapy |
| Q48342432 | Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review |
| Q57065766 | Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group |
| Q38772303 | Medicaid Participation among Liver Transplant Candidates after the Affordable Care Act Medicaid Expansion |
| Q90615513 | Mentor of the Month Series: How to Review a Manuscript from an Editor's Perspective? |
| Q87094565 | Metabolic syndrome-associated hepatocellular carcinoma: Questions still unanswered |
| Q39714372 | Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer |
| Q39015995 | MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. |
| Q90221133 | Minimally Invasive Liver Resection for Early-Stage Hepatocellular Carcinoma: Inconsistent Outcomes from Matched or Weighted Cohorts |
| Q58544849 | Minimally Invasive Oncologic Surgery |
| Q37604137 | Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients. |
| Q57171466 | Minimally Invasive Versus Open Primary Resection for Retroperitoneal Soft Tissue Sarcoma: A Propensity-Matched Study From the National Cancer Database |
| Q39604699 | Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database |
| Q49352080 | Minimally invasive hepatopancreatobiliary surgery: Where do we go from here? |
| Q50179184 | Minimally invasive resection of choledochal cyst: a feasible and safe surgical option. |
| Q90006822 | Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group |
| Q52683913 | Minimally invasive versus open surgery in the Medicare population: a comparison of post-operative and economic outcomes. |
| Q90379764 | Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis |
| Q50041699 | Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach? |
| Q90019968 | Molecular Diagnosis of Cystic Neoplasms of the Pancreas: a Review |
| Q90336986 | Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma |
| Q38938329 | Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer. |
| Q90200385 | Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review |
| Q91323880 | Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection |
| Q99576233 | Moving Toward a More Informed Approach to Risk Stratification of Patients: Comments on Seror et al. CT-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related HCC |
| Q95276195 | Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis |
| Q36839003 | Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension |
| Q35674607 | Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management |
| Q38130469 | Multidisciplinary approaches to intrahepatic cholangiocarcinoma |
| Q42547502 | Multidisciplinary clinic in the management of hepatocellular carcinoma |
| Q41963215 | Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation |
| Q38222988 | Multimodal treatment strategies for advanced hilar cholangiocarcinoma |
| Q33621543 | Multimodality imaging of intrahepatic cholangiocarcinoma |
| Q46261268 | Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy |
| Q51615257 | Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. |
| Q40403888 | National Trends in Postoperative Outcomes and Cost Comparing Minimally Invasive Versus Open Liver and Pancreatic Surgery |
| Q44459706 | National Trends in the Management and Survival of Surgically Managed Gallbladder Adenocarcinoma Over 15 years: A Population-Based Analysis |
| Q38171293 | National assessment of margin status as a quality indicator after pancreatic cancer surgery |
| Q40003430 | National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. |
| Q36416331 | National trends in the use of surgery for benign hepatic tumors in the United States |
| Q36064774 | National trends with a laparoscopic liver resection: results from a population-based analysis. |
| Q90052729 | Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors |
| Q33809495 | Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival |
| Q41723373 | Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model. |
| Q45064136 | Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery |
| Q33925521 | Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival |
| Q30274866 | Neuroendocrine liver metastasis: The chance to be cured after liver surgery |
| Q83256738 | Neuroendocrine liver metastasis: transplant as part of multimodality liver-directed therapy |
| Q39493707 | Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization |
| Q91418588 | New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors |
| Q53078402 | No small issue: Hepatectomies-minimally invasive but more-than-minimally biased toward minor resections? |
| Q85942335 | Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma? |
| Q49966883 | Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group |
| Q37140005 | Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. |
| Q36304275 | Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative |
| Q46246474 | Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival |
| Q44110160 | Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin |
| Q50061765 | Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes: A Reply |
| Q87749412 | Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes |
| Q38526335 | Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results |
| Q38644019 | Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Met |
| Q37081489 | Operative mortality after hepatic resection: are literature-based rates broadly applicable? |
| Q41253004 | Optimal Transfusion Trigger in Surgical Patients With Coronary Artery Disease |
| Q36922168 | Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative |
| Q41116299 | Organizing a multidisciplinary clinic |
| Q91872642 | Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume |
| Q37119591 | Outcomes after resection of cortisol-secreting adrenocortical carcinoma |
| Q47422417 | Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. |
| Q43961172 | Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study |
| Q37119581 | Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group |
| Q56975864 | Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative |
| Q93055625 | Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database |
| Q88990670 | Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature |
| Q37530665 | Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges? |
| Q45194477 | Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas |
| Q94557929 | Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer |
| Q34676671 | Packed red blood cell transfusion after surgery: are we "overtranfusing" our patients? |
| Q34583751 | Palliation of hepatic tumors |
| Q36626643 | Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience |
| Q81952353 | Pancreatic resection of isolated metastases from nonpancreatic primary cancers |
| Q38166659 | Pancreaticoduodenectomy after bariatric surgery: challenges and available techniques for reconstruction |
| Q44807007 | Pancreaticoduodenectomy: time to change our approach? |
| Q38863746 | Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review |
| Q30239947 | Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes |
| Q40110412 | Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium |
| Q89734799 | Pathologic complete response following neoadjuvant therapy for pancreatic ductal adenocarcinoma: defining the incidence, predictors, and outcomes |
| Q48146966 | Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. |
| Q93090576 | Patient Perceptions About the Role of Religion and Spirituality During Cancer Care |
| Q36915703 | Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer. |
| Q51364206 | Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. |
| Q33733143 | Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies |
| Q37061727 | Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases |
| Q47328496 | Patient-Provider Communication and Health Outcomes Among Individuals with Hepato-Pancreato-Biliary Disease in the USA. |
| Q89118555 | Patient-provider relationships and health outcomes among hepatopancreatobiliary patients |
| Q91390093 | Patients From Appalachia Have Reduced Access to Liver Transplantation After Wait-Listing |
| Q36520529 | Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma |
| Q41061778 | Patterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-targeted hepatectomy database |
| Q37727827 | Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US. |
| Q37333807 | Patterns of hepatic resections in North America: use of concurrent partial resections and ablations |
| Q36370711 | Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site |
| Q39212345 | Pediatric choledochal cysts: diagnosis and current management |
| Q36421718 | Pelvic exenteration for advanced pelvic malignancies |
| Q45063217 | Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma |
| Q82418582 | Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter? |
| Q82670764 | Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective |
| Q33742377 | Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. |
| Q40525272 | Perioperative Hyperglycemia and Postoperative Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases |
| Q35645739 | Perioperative Management of Hilar Cholangiocarcinoma |
| Q90031576 | Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis |
| Q38661081 | Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy |
| Q49345343 | Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma |
| Q88461292 | Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery |
| Q47330535 | Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma |
| Q90222684 | Perioperative use of blood products is associated with risk of morbidity and mortality after surgery |
| Q89214723 | Peritoneal Malignancies |
| Q120646068 | Persistent poverty impacts access to minimally invasive surgery among patients with hepatopancreatobiliary cancer |
| Q38675282 | Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response |
| Q38642688 | Personalized treatment in patients with colorectal liver metastases |
| Q38966189 | Personalized treatment of patients with very early hepatocellular carcinoma |
| Q35202400 | Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma |
| Q35067737 | Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. |
| Q36625954 | Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma |
| Q36681218 | Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury |
| Q28247867 | Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma |
| Q91336518 | Photodynamic therapy may provide a benefit over systemic chemotherapy among non-surgically managed patients with extrahepatic cholangiocarcinoma |
| Q38746599 | Physiologic correlates of intraoperative blood transfusion among patients undergoing major gastrointestinal operations |
| Q90759134 | Population-Based Assessment of Selective Drain Placement During Pancreatoduodenectomy Using the Modified Fistula Risk Score |
| Q82800931 | Portal vein encasement complicates resection of Klatskin's tumor |
| Q89902661 | Post Hepatectomy Liver Failure Risk Calculator for Preoperative and Early Postoperative Period Following Major Hepatectomy |
| Q33720763 | Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases |
| Q39420015 | Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management |
| Q93382534 | Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy-Stratification of Patient Risk |
| Q48172400 | Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients |
| Q54267871 | Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma. |
| Q87470858 | Potential Barriers to the Diffusion of Surgical Innovation |
| Q40970331 | Potential Economic Impact of Using a Restrictive Transfusion Trigger Among Patients Undergoing Major Abdominal Surgery. |
| Q47239432 | Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma |
| Q90717525 | Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis |
| Q88264369 | Practical Guide to Surgical Data Sets: National Surgical Quality Improvement Program (NSQIP) and Pediatric NSQIP |
| Q89483614 | Practices and Perceptions Among Surgical Oncologists in the Perioperative Care of Obese Cancer Patients |
| Q37484579 | Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? |
| Q88946329 | Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers |
| Q91401574 | Precision Medicine in Surgical Oncology |
| Q98212680 | Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma |
| Q114235906 | Predicting overall and recurrence‐free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi‐institutional analysis |
| Q53091755 | Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. |
| Q47624466 | Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer. |
| Q80380578 | Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy |
| Q90977502 | Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? |
| Q90346870 | Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
| Q44891392 | Predictors of survival after resection of early hepatocellular carcinoma |
| Q34997139 | Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system |
| Q40339038 | Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma |
| Q47253947 | Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma |
| Q42617266 | Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility |
| Q38661967 | Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases. |
| Q84842058 | Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a haystack? Comment on "prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injury" |
| Q80305396 | Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome |
| Q56334495 | Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection |
| Q30300026 | Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis |
| Q63471494 | Presentation and Management of Gastrointestinal Stromal Tumors of the Duodenum: A Multi-Institutional Analysis |
| Q30432108 | Pretreatment assessment of hepatocellular carcinoma: expert consensus statement |
| Q33554179 | Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma |
| Q38019362 | Primary biliary tract melanoma: Report of a case and review of the literature |
| Q85037256 | Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows |
| Q46601639 | Primary sclerosing cholangitis: role of extrahepatic biliary resection |
| Q37618721 | Primary sclerosing cholangitis: the role of extrahepatic biliary resection |
| Q34461341 | Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis |
| Q44124151 | Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene |
| Q91567399 | Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification |
| Q90971240 | Prognosis and Adherence with the National Comprehensive Cancer Network Guidelines of Patients with Biliary Tract Cancers: an Analysis of the National Cancer Database |
| Q48515344 | Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients |
| Q38847613 | Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location. |
| Q33742418 | Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study |
| Q64967755 | Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. |
| Q38954887 | Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases. |
| Q87173280 | Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging |
| Q38958328 | Prognostic impact of complications after resection of early stage hepatocellular carcinoma |
| Q120212677 | Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study |
| Q40219176 | Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer |
| Q49966825 | Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases. |
| Q91534513 | Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients |
| Q38890459 | Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma |
| Q50118274 | Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors |
| Q84570385 | Propensity score methods: setting the score straight |
| Q41439902 | Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. |
| Q33236750 | Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein |
| Q51220969 | Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomy. |
| Q35177885 | Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival |
| Q97684232 | Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition |
| Q44955762 | Quality improvement in gastrointestinal surgical oncology with American College of Surgeons National Surgical Quality Improvement Program |
| Q91433043 | Quality in a Shifting Payment Landscape and the Implications for Surgical Oncology |
| Q89630963 | Quality of Care Among Medicare Patients Undergoing Pancreatic Surgery: Safety Grade, Magnet Recognition, and Leapfrog Minimum Volume Standards-Which Quality Benchmark Matters? |
| Q122171942 | Quality of ChatGPT Responses to Questions Related To Liver Transplantation |
| Q121752389 | Quality of ChatGPT Responses to Questions Related to Pancreatic Cancer and its Surgical Care |
| Q40815314 | Quality of life after treatment of neuroendocrine liver metastasis. |
| Q51250036 | Race-based differences in length of stay among patients undergoing pancreatoduodenectomy. |
| Q100563379 | Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery |
| Q36540044 | Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States |
| Q34443391 | Racial disparity in surgical mortality after major hepatectomy |
| Q90474179 | Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer |
| Q91299157 | Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report |
| Q90094697 | Radiographic characteristics of neuroendocrine liver metastases do not predict clinical outcomes following liver resection |
| Q36764997 | Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results |
| Q37391705 | Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium |
| Q87653580 | Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis |
| Q53187956 | Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. |
| Q36626551 | Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma |
| Q37285956 | Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions |
| Q81551256 | Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark |
| Q39832119 | Readmission Following Gastric Cancer Resection: Risk Factors and Survival |
| Q39354700 | Readmission after major surgery: effect of the postdischarge environment |
| Q91367114 | Readmission after pancreatic resection: causes, costs and cost-effectiveness analysis of high versus low quality hospitals using the Nationwide Readmission Database |
| Q38257941 | Readmission after surgery |
| Q35805832 | Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre |
| Q90205074 | Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study |
| Q91862530 | Reciprocity within patient-physician and patient-spouse/caregiver dyads: insights into patient-centered care |
| Q90292124 | Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma |
| Q30412886 | Recurrence after operative management of intrahepatic cholangiocarcinoma |
| Q96820910 | Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model |
| Q33720753 | Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis |
| Q40607264 | Red Cell Transfusion Triggers and Postoperative Outcomes After Major Surgery. |
| Q91859656 | Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients |
| Q37727829 | Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study |
| Q24633990 | Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion |
| Q102370323 | Refusal of Surgery Among Patients with Early-Stage Hepato-Pancreato-Biliary Cancers: Predictive Factors and Outcomes |
| Q30399196 | Regret in Surgical Decision Making: A Systematic Review of Patient and Physician Perspectives. |
| Q43891590 | Regulation of herpes simplex virus 1 replication using tumor-associated promoters |
| Q34790267 | Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5. |
| Q45261010 | Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis |
| Q88557101 | Reply to "Poorly differentiated clusters in colorectal liver metastases: Prognostic significance in synchronous and metachronous metastases" |
| Q88847817 | Reply to Li et al. "Can Preoperative Frailty Accurately Predict Morbidity and Mortality Following Liver Surgery?" |
| Q42821746 | Reply to Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer |
| Q87070437 | Reply to: epidural analgesia utilization rate for hepatic and pancreatic surgery, that low? |
| Q87122482 | Reply: To PMID 23890842 |
| Q36567678 | Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients |
| Q38206274 | Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options |
| Q104751119 | Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis |
| Q35155573 | Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships |
| Q80051843 | Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival |
| Q41852206 | Resection of non-hepatic colorectal cancer metastasis |
| Q53089236 | Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. |
| Q91499875 | Response to comments on "Impact of tumor size and nodal status on the recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: a multi-institutional study of 392 cases" |
| Q56362861 | Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study |
| Q36511757 | Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver |
| Q84307512 | Risk factors for pancreatic leak after distal pancreatectomy |
| Q39591993 | Risk of morbidity and mortality following hepato-pancreato-biliary surgery |
| Q88990276 | Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database |
| Q38581192 | Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors |
| Q58554455 | Role of associating liver partition and portal vein ligation in staged hepatectomy (ALPPS)-strategy for colorectal liver metastases |
| Q35826593 | Role of cell cycle in mediating sensitivity to radiotherapy |
| Q38625386 | Role of exosomes in treatment of hepatocellular carcinoma |
| Q90825193 | Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition? |
| Q90518922 | Routine intensive care unit admission among patients undergoing major pancreatic surgery for cancer: No effect on failure to rescue |
| Q38946592 | Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium |
| Q84807965 | Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis |
| Q52688526 | Safety and oncologic outcomes of robotic liver resections: A systematic review. |
| Q35096126 | Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors |
| Q35097594 | Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis |
| Q38804049 | Sarcopenia predicts costs among patients undergoing major abdominal operations |
| Q46925633 | Scientific impact of Association for Academic Surgery and Society of University Surgeons plenary session abstracts increases in the era of the Academic Surgical Congress from 2006 to 2010. |
| Q35565067 | See one, do one, and teach none: resident experience as a teaching assistant |
| Q42015190 | Segmental atrophy of the liver: an uncommon and often unrecognized pseudotumor. |
| Q30415026 | Selection for hepatic resection of colorectal liver metastases: expert consensus statement |
| Q53522081 | Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. |
| Q45657370 | Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen |
| Q36120986 | Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies |
| Q56362683 | Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma |
| Q40843432 | Sex- and age-based variation in transfusion practices among patients undergoing major surgery. |
| Q100753857 | Sex-based differences in time to surgical care among pancreatic cancer patients: A national study of Medicare beneficiaries |
| Q36790166 | Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases |
| Q36598926 | Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis |
| Q92191753 | Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis |
| Q31146320 | Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry |
| Q34460281 | Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch |
| Q81100663 | Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis |
| Q50064113 | Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation |
| Q35187065 | Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms. |
| Q39399561 | Solid Pseudopapillary Tumor of the Pancreas: A Single-center Experience and Review of the Literature |
| Q34567525 | Solitary colorectal liver metastasis: resection determines outcome |
| Q90435104 | Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy |
| Q37261411 | Spirituality and religion in the care of surgical oncology patients with life-threatening or advanced illnesses |
| Q39976704 | Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative. |
| Q47915968 | Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
| Q90755996 | Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions |
| Q81100405 | Staging of hepatocellular carcinoma |
| Q37697466 | Staging of intrahepatic cholangiocarcinoma |
| Q37675065 | Staging of intrahepatic cholangiocarcinoma. |
| Q49937918 | Steps to Getting Your Manuscript Published in a High-Quality Medical Journal |
| Q50074188 | Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective. |
| Q37715120 | Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: a dosimetric analysis |
| Q79956495 | Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma |
| Q89924465 | Suction or Gravity: Impact of Closed-System Drain Type on the Postoperative Outcomes of Pancreatoduodenectomy |
| Q78609149 | Supernumerary intravagal parathyroid hyperplasia |
| Q38819071 | Surgeon-Level Variation in Postoperative Complications. |
| Q58545477 | Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms |
| Q53151516 | Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. |
| Q85042662 | Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer |
| Q88191368 | Surgical Management of Choledocholithiasis: A Disappearing Skill |
| Q49331762 | Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes |
| Q53076652 | Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema. |
| Q88731058 | Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan |
| Q36244515 | Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey. |
| Q50239371 | Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer |
| Q40044470 | Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies. |
| Q88567949 | Surgical approaches for the treatment of perihilar cholangiocarcinoma |
| Q30458739 | Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients |
| Q81795140 | Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? |
| Q43417095 | Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis |
| Q53405426 | Surgical management of neuroendocrine tumors: treatment of localized and metastatic disease. |
| Q38224364 | Surgical management of noncolorectal cancer liver metastases |
| Q37715123 | Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis |
| Q35030363 | Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series |
| Q43080471 | Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome |
| Q36832322 | Surgical therapy for colorectal metastases to the liver |
| Q37715129 | Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis |
| Q37175948 | Surgical treatment of double primary liver cancer: An observational study for a rare type of tumor |
| Q35648688 | Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations |
| Q87481141 | Surveillance for hepatocellular carcinoma with ultrasound and AFP is associated with improvements in tumour detection, receipt of curative therapy and overall survival in patients with cirrhosis |
| Q41413366 | Survival Following Lung Metastasectomy in Soft Tissue Sarcomas |
| Q53263862 | Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases. |
| Q84982315 | Survival benefit of liver transplantation and the effect of underlying liver disease |
| Q48605647 | Suspected ethical misconduct in research |
| Q34618754 | Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges. |
| Q89146322 | Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery |
| Q50052876 | Systemic treatment and primary tumor location in patients with metastatic colorectal cancer |
| Q38067629 | Technology-assisted versus clamp-crush liver resection: a systematic review and meta-analysis |
| Q94571452 | Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond |
| Q44905186 | Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. |
| Q35047746 | Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years |
| Q57146124 | Ten-year reassessment of the shortage of general surgeons: Increases in graduation numbers of general surgery residents are insufficient to meet the future demand for general surgeons |
| Q90172366 | The Association Between Patient Satisfaction and Patient-Reported Health Outcomes |
| Q89273079 | The Cost of Complications Following Major Resection of Malignant Neoplasia |
| Q88946338 | The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample |
| Q92379432 | The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery |
| Q88598850 | The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis |
| Q56342241 | The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study |
| Q52689977 | The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma. |
| Q90548223 | The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma |
| Q30300388 | The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma |
| Q94957401 | The Landmark Series: Intrahepatic Cholangiocarcinoma |
| Q49907714 | The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma |
| Q35845002 | The Orphan Drug Act: Restoring the Mission to Rare Diseases |
| Q38684846 | The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion |
| Q40756645 | The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. |
| Q57172702 | The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases |
| Q53645661 | The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases. |
| Q35695811 | The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience |
| Q47265665 | The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors |
| Q96340933 | The beliefs of cancer care providers regarding the role of religion and spirituality within the clinical encounter |
| Q35869431 | The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer |
| Q30274956 | The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis |
| Q37774182 | The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography |
| Q90735132 | The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors |
| Q64943012 | The evolving field of intrahepatic cholangiocarcinoma. |
| Q36392018 | The evolving role of proteomics in the early detection of breast cancer. |
| Q37337144 | The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome |
| Q89348604 | The impact of a malignant diagnosis on the pattern and outcome of readmission after liver and pancreatic surgery: An analysis of the nationwide readmissions database |
| Q50117362 | The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium |
| Q45062084 | The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis. |
| Q56333913 | The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma |
| Q30238553 | The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review |
| Q48024049 | The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. |
| Q35679643 | The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma |
| Q49591368 | The impact of the aging population and incidence of cancer on future projections of general surgical workforce needs |
| Q38667260 | The importance of surgical margins in primary malignancies of the liver |
| Q39195935 | The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative. |
| Q39087992 | The price of surgery: markup of operative procedures in the United States |
| Q91810839 | The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis |
| Q39238657 | The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis. |
| Q48098253 | The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases. |
| Q90642658 | The relationship of hospital market concentration, costs, and quality for major surgical procedures |
| Q40226836 | The relative effect of hospital and surgeon volume on failure to rescue among patients undergoing liver resection for cancer. |
| Q51009835 | The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. |
| Q98777596 | The religious/spiritual beliefs and needs of cancer survivors who underwent cancer-directed surgery |
| Q80405340 | The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes |
| Q36598896 | The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma |
| Q30276213 | The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis |
| Q37831218 | The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support? |
| Q48154170 | The role of platelets on regenerating liver: Thoughts beyond parenchymal proliferation |
| Q36838988 | The role of radiation in retroperitoneal sarcomas: a surgical perspective |
| Q38366159 | The role of radiation therapy in pancreatic ductal adenocarcinoma in the neoadjuvant and adjuvant settings |
| Q87505464 | The timing of complications impacts risk of readmission after hepatopancreatobiliary surgery |
| Q43480850 | The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship |
| Q92452628 | Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? |
| Q53163559 | Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. |
| Q93004093 | Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis |
| Q37734112 | Thermal ablative therapies for secondary hepatic malignancies |
| Q91332738 | Three Common Methodological Issues in Studies of Surgical Readmission Rates: The Trouble With Readmissions |
| Q57169573 | Time to Readmission and Mortality Among Patients Undergoing Liver and Pancreatic Surgery |
| Q88177504 | Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer |
| Q38948852 | Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis |
| Q45068093 | Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis. |
| Q79774684 | Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis |
| Q47957523 | To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer. |
| Q45104230 | Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival |
| Q85855489 | Total pancreatectomy for the management of refractory post-gastric bypass hypoglycemia |
| Q35703275 | Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission |
| Q39031511 | Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America. |
| Q50323331 | Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma |
| Q89596017 | Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis |
| Q48715194 | Transitoriness in cancer patients: a cross-sectional survey of lung and gastrointestinal cancer patients |
| Q50076272 | Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. |
| Q96232327 | Travel Patterns among Patients Undergoing Hepatic Resection in California: Does Driving Further for Care Improve Outcomes? |
| Q36537666 | Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. |
| Q38203465 | Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis |
| Q36130514 | Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective |
| Q94676144 | Treatment of neuroendocrine liver metastases: a patent landscape review |
| Q38134328 | Treatment options and surveillance strategies after therapy for hepatocellular carcinoma |
| Q37691453 | Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma |
| Q46572619 | Trends and risk factors for transfusion in hepatopancreatobiliary surgery |
| Q41187246 | Trends in Hospital Volume and Failure to Rescue for Pancreatic Surgery. |
| Q90783414 | Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma |
| Q46236842 | Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. |
| Q81100678 | Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis |
| Q92515121 | Trends in the Geospatial Distribution of Adult Inpatient Surgical Cancer Care Across the United States |
| Q38635553 | Trends in the Mortality of Hepatocellular Carcinoma in the United States |
| Q91985418 | Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis |
| Q90314406 | Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy |
| Q51786105 | Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy. |
| Q37357779 | Trends in the quality of highly cited surgical research over the past 20 years |
| Q52587850 | Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. |
| Q39626850 | Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases |
| Q103811848 | Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? |
| Q103046401 | Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma |
| Q47173104 | Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma |
| Q47370771 | Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma |
| Q99587368 | Tumour Burden Score: An Authentic, Easy-To-Use Prognostic Marker for Hepatocellular Carcinoma |
| Q33865026 | Two-stage strategy for patients with extensive bilateral colorectal liver metastases. |
| Q91078660 | U.S. News and World Report hospital ranking and surgical outcomes among patients undergoing surgery for cancer |
| Q40658392 | Understanding Variation in 30-Day Surgical Readmission in the Era of Accountable Care: Effect of the Patient, Surgeon, and Surgical Subspecialties |
| Q36160730 | Understanding drivers of hospital charge variation for episodes of care among patients undergoing hepatopancreatobiliary surgery |
| Q91320542 | Understanding patient expectations around therapeutic benefits, risks, and the chance of cure |
| Q39785344 | Understanding recurrent readmission after major surgery among patients with employer-provided health insurance |
| Q36806943 | Understanding surgical decision making in early hepatocellular carcinoma |
| Q90773278 | Understanding the use of attachment theory applied to the patient-provider relationship in cancer care: Recommendations for future research and clinical practice |
| Q33720726 | Unnecessary tests and procedures in patients presenting with solid tumors of the pancreas |
| Q37039550 | Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria |
| Q38101549 | Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy |
| Q55257627 | Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency. |
| Q49341121 | Update on current problems in colorectal liver metastasis |
| Q47860447 | Updates and Critical Insights on Glissonian Approach in Liver Surgery |
| Q39348019 | Updates in hepatic oncology imaging |
| Q92440268 | Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery |
| Q85680634 | Use of endoscopic ultrasound in the preoperative staging of gastric cancer: a multi-institutional study of the US gastric cancer collaborative |
| Q91339237 | Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery |
| Q31139242 | Use of the Modified Frailty Index in the American College of Surgeons National Surgical Improvement Program Database: Highlighting the Problem of Missing Data |
| Q44457674 | Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative |
| Q97684237 | Utilization of High-Volume Hospitals for High-Risk Cancer Surgery in California Following Medicaid Expansion |
| Q91158140 | Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines |
| Q48808465 | Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection. |
| Q53488448 | Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative. |
| Q88430512 | Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? |
| Q39641951 | Variation in crystalloid administration: an analysis of 6248 patients undergoing major elective surgery. |
| Q39460316 | Variation in inpatient hospital and physician payments among patients undergoing general versus orthopedic operations. |
| Q36598915 | Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? |
| Q89809747 | Variation in markup of general surgical procedures by hospital market concentration |
| Q85842854 | Variation in readmission by hospital after colorectal cancer surgery |
| Q40525458 | Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resections. |
| Q96023557 | Variations in Healthcare Expenditures Among Medicare Beneficiaries Undergoing Resection of Pancreatic Cancer |
| Q36071918 | Variations in hospitals costs for surgical procedures: inefficient care or sick patients? |
| Q36149554 | Variations in surgical outcomes associated with hospital compliance with safety practices |
| Q33415676 | Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons |
| Q37822607 | Volume-based trends in thyroid surgery |
| Q35073497 | Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. |
| Q60685187 | What Are Patients' Expectations about the Effects of Chemotherapy for Advanced Cancer? |
| Q35679802 | What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? |
| Q36019665 | What to expect when you're expecting a hepatopancreatobiliary surgeon: self-reported experiences of HPB surgeons from different training pathways. |
| Q53391179 | When Do We Stop, and How Do We Do It? Medical Futility and Withdrawal of Care |
| Q47568371 | Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis |
| Q49949264 | Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis: Reply |
| Q42951101 | Withdrawing Medically Futile Treatment |
| Q36492784 | Withholding and withdrawing life-sustaining treatment: a surgeon's perspective |
| Q88128674 | Worse outcomes among uninsured general surgery patients: does the need for an emergency operation explain these disparities? |
| Q36693966 | Young patients undergoing resection of pancreatic cancer fare better than their older counterparts |
Search more.